Astrocytoma Drug Market is driven by Targeted Therapy Innovations

ha aggiunto una foto Altre informazioni

2 mesi fa -

The Astrocytoma Drug Market encompasses a range of pharmaceutical therapies designed to treat astrocytoma, a malignant brain tumor arising from astrocytes. Key products include alkylating agents like temozolomide, anti-VEGF antibodies such as bevacizumab, and novel small-molecule inhibitors targeting molecular pathways (e.g., EGFR, BRAF). Astrocytoma Drug Market Innovative drug formulations...

0 Commenti 0 condivisioni 425 Views 0 Anteprima